EMA Authorised: Insulin lispro Sanofi (insulin lispro) — Sanofi Winthrop Industrie

View source ↗

Summary

The EMA authorised a medicinal product insulin lispro Sanofi for diabetes mellitus, with Sanofi Winthrop Industrie as the marketing authorization holder, decisi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Insulin lispro Sanofi (insulin lispro)

Snippet

Status: Authorised. Therapeutic area: Diabetes Mellitus. MAH: Sanofi Winthrop Industrie. Decision date: 28/01/2026